Figure 2.

This figure presents (a) the type of therapy in the first line of therapy (LoT) and the second LoT. The type of therapy is divided into monotherapy and doublet, triplet, quadruplet or other regimens. The second figure (b) shows the type of medication in the first and second LoT. The medications are classified into the following groups: immunomodulators, proteasome inhibitors, Ps and proteasome inhibitors, chemotherapy, antibody, clinical trial, or others. In (a,b), patients are categorized into two groups: those eligible for transplantation (SCT Eligible) and those ineligible for SCT (SCT Ineligible). In the last figure (c), the type of medication and therapy is given for all patients in the third LoT as one group due to the limited number of patients.